Apellis Pharmaceuticals, Inc.

APLS stock is not Shariah-compliant

مدعوم بواسطة Zoya API

About Apellis Pharmaceuticals, Inc. (APLS)

Apellis Pharmaceuticals is a commercial-stage biopharmaceutical company focused on the discovery, development, and commercialization of therapeutic compounds that inhibit the complement system for autoimmune and inflammatory diseases. Its lead product candidate, pegcetacoplan, is in Phase III clinical trials for the treatment of geographic atrophy in age-related macular degeneration and paroxysmal nocturnal hemoglobinuria. The company also develops other candidates for various diseases, including cold agglutinin disease, hematopoietic stem cell transplantation-associated thrombotic microangiopathy, C3 glomerulopathy, immune complex membranoproliferative glomerulonephritis, and amyotrophic lateral sclerosis.

الأسئلة المتداولة

Is Apellis Pharmaceuticals, Inc. (APLS) stock halal to invest in?
Yes, APLS is not Shariah-compliant based on the company’s latest financial reports and therefore considered halal to invest in. Last updated on Aug 27, 2024.
No, APLS is not Shariah-compliant based on the company’s latest financial reports and therefore not considered halal to invest in. Last updated on Aug 27, 2024.
As of Aug 27, 2024, Apellis Pharmaceuticals, Inc. (APLS) stock is flagged as not Shariah-compliant in terms of Shariah compliance. This means that while the company's operations do not definitively violate Islamic guidelines, there are certain aspects of Apellis Pharmaceuticals, Inc.'s business that require careful consideration.
Does Apellis Pharmaceuticals, Inc. have any interest income?
Yes, Apellis Pharmaceuticals, Inc. does have interest income. According to the company's latest annual report for the fiscal year ending Dec 31, 2023, Apellis Pharmaceuticals, Inc. reported revenue of 396591000 and interest income of 20933000. The interest income represents 5.01% of the combined total. It's worth noting that some companies may report additional interest income as part of their revenue. For a detailed breakdown of all interest income and revenue segments, please refer to the full Shariah compliance report available in the Zoya app.
No, Apellis Pharmaceuticals, Inc. has not reported any interest income. According to the company's latest annual report for the fiscal year ending Dec 31, 2023, Apellis Pharmaceuticals, Inc. reported total revenue of 396591000, with no separate interest income disclosed. However, it's worth noting that some companies may report interest income as part of their revenue. For a detailed breakdown of all interest income and revenue segments, please refer to the full Shariah compliance report available in the Zoya app.
What guidelines are used to determine if Apellis Pharmaceuticals, Inc. stock is Shariah-compliant?
نحن نستخدم المبادئ التوجيهية التي وضعتها هيئة المحاسبة والمراجعة للمؤسسات المالية الإسلامية (AAOIFI) لتقييم الامتثال للشريعة الإسلامية. هيئة المحاسبة والمراجعة للمؤسسات المالية الإسلامية هي منظمة دولية رائدة تضع معايير التمويل الإسلامي. تساعد إرشاداتها في تحديد ما إذا كانت الأنشطة التجارية للشركة و والهيكل المالي يتماشى مع المبادئ الإسلامية. وتحظى هذه المعايير باحترام واسع النطاق في وتوفر إطارًا متسقًا لتقييم مدى توافق الأسهم والأدوات المالية الأخرى مع الشريعة الإسلامية. والأدوات المالية الأخرى. وتضم الهيئة الشرعية لهيئة المحاسبة والمراجعة للمؤسسات المالية الإسلامية علماء مشهورين مثل الشيخ محمد تقي عثماني، والشيخ عبد الستار أبو غدة، والشيخ عبد الله المانع.
How often is Apellis Pharmaceuticals, Inc. stock reviewed for Shariah compliance?
The Shariah compliance status of Apellis Pharmaceuticals, Inc. stock is reviewed on a regular basis, with a minimum frequency of once per quarter. However, if there are any significant changes or major developments in the company's operations that may impact its compliance, an immediate review will be conducted to ensure ongoing adherence to Shariah principles.
How can I stay updated on Apellis Pharmaceuticals, Inc.'s compliance status?
To stay informed, we recommend regularly checking Zoya for updates. You can also enable alerts within the Zoya app to receive notifications whenever there is a change in the Shariah compliance of APLS, or any other stocks you are monitoring. This is particularly useful as Shariah compliance can fluctuate due to changes in a company's financial ratios or business activities.
Are dividends from Apellis Pharmaceuticals, Inc. stock considered halal?
Yes, dividends from APLS are considered halal. However, you may need to purify a portion of the dividend if the company has any impermissible revenue. Shariah standards typically allow up to 5% of revenue from impermissible sources for a stock to remain compliant. To find the exact percentage of impermissible revenue for Apellis Pharmaceuticals, Inc. (APLS), check the Zoya app. For more details on the purification process, read our comprehensive guide.
No, dividends from APLS are not considered halal because the stock is currently not Shariah-compliant. When a stock is non-compliant, any dividends received from it are considered impermissible income and should be donated to charity as a form of purification. To learn more about the purification process and how to handle impermissible income, read our comprehensive guide.
Do I need to pay Zakat on my Apellis Pharmaceuticals, Inc. shares?
If you hold Apellis Pharmaceuticals, Inc. stock as an investment, through an Employee Stock Ownership Plan (ESOP), stock options, restricted stock units (RSUs), or any other form of stock ownership, and meet the Nisab threshold, you may be required to pay Zakat on it. The calculation of Zakat on stocks can be complex and depends on various factors. To help make this easy, we've created a free Zakat calculation tool. For an even easier experience, use the Zoya mobile app, where you can link your brokerage account to automatically import holdings.

How to buy Apellis Pharmaceuticals, Inc. (APLS) stock on Zoya

  1. سجّل للحصول على حساب زويا مجاناً
    من السهل البدء. يمكنك التسجيل للحصول على حساب مباشرةً على موقعنا الإلكتروني أو عن طريق تنزيل تطبيق زويا لنظامي iOS أو أندرويد.
  2. اربط حساب وساطة
    تتعاون Zoya مع شركات وساطة رائدة مثل Alpaca وغيرها من أجل طريقة سلسة لشراء الأسهم وإدارتها من خلال Zoya.
  3. حدد المبلغ الذي تريد استثماره
    انتقل إلى شاشة البحث واكتب اسم السهم في شريط البحث. بعد ذلك، انقر على زر الشراء وأدخل المبلغ الذي ترغب في استثماره، سواء بالدولار أو عدد الأسهم. راجع سعر السهم في الوقت الحقيقي وكمية الأسهم المقدرة قبل تأكيد استثمارك.
  4. قم بإدارة محفظتك في مكان واحد
    يمكنك العثور على الأسهم التي اشتريتها حديثًا في محفظة Zoya الخاصة بك إلى جانب بقية ممتلكاتك. قم بتمكين التنبيهات للحصول على إشعارات بأي تغييرات في امتثال محفظتك للشريعة الإسلامية.

منشورات المنتدى

الأسهم ذات الصلة

See how Apellis Pharmaceuticals, Inc. compares with its peers: